Cargando…
Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor–Positive Human Epidermal Growth Factor Receptor-2–Negative Early Breast Cancer Without Chemotherapy
IMPORTANCE: Studies have shown that delayed initiation of surgery and adjuvant chemotherapy is associated with lower rates of breast cancer survival. However, it remains unclear whether delayed initiation of adjuvant hormone therapy (AHT) is associated with survival. OBJECTIVE: To assess the associa...
Autores principales: | Fu, Fangmeng, Yu, Liuwen, Zeng, Bangwei, Chen, Minyan, Guo, Wenhui, Chen, Lili, Lin, Yuxiang, Hou, Jialin, Li, Jing, Li, Yan, Li, Shengmei, Chen, Xiaobin, Zhang, Wenzhe, Jin, Xuan, Cai, Weifeng, Zhang, Kun, Chen, Hanxi, Qiu, Yibin, Nie, Qian, Wang, Chuan, Jacobs, Lisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848199/ https://www.ncbi.nlm.nih.gov/pubmed/35166783 http://dx.doi.org/10.1001/jamanetworkopen.2021.45934 |
Ejemplares similares
-
High leukocyte mitochondrial DNA copy number contributes to poor prognosis in breast cancer patients
por: Zhang, Wenzhe, et al.
Publicado: (2023) -
Clinical application of artificial neural network (ANN) modeling to predict BRCA1/2 germline deleterious variants in Chinese bilateral primary breast cancer patients
por: Li, Yan, et al.
Publicado: (2022) -
Evaluating the Survival Benefit Following Ovarian Function Suppression in Premenopausal Patients with Hormone Receptor Positive Early Breast Cancer
por: Qiu, Lin, et al.
Publicado: (2016) -
YTHDF3 facilitates triple-negative breast cancer progression and metastasis by stabilizing ZEB1 mRNA in an m(6)A-dependent manner
por: Lin, Yuxiang, et al.
Publicado: (2022) -
Impact of body mass index in therapeutic response for HER2 positive breast cancer treated with neoadjuvant targeted therapy: a multi-center study and meta-analysis
por: Chen, Lili, et al.
Publicado: (2023)